GLP-1 Weight-Loss Injections Explained: How They Actually Work

Few health stories have moved as fast as the rise of GLP-1 weight-loss injections. In the space of a couple of years they have gone from a niche diabetes treatment to a mainstream topic at the dinner table, with an estimated 1.5 million UK adults using them by early 2025 and around 4 million Britons having tried them at some point. Searches for one brand alone climbed from roughly 100 a month in 2021 to more than 900,000 a month by 2025.

Yet for all the headlines, remarkably few explanations get past the buzzwords. What actually is a GLP-1? Why does a weekly injection make people eat less? And why are these treated as serious prescription medicines rather than an over-the-counter shortcut? This guide answers those questions in plain English. It is purely educational: GLP-1 medicines are prescription-only, and the decision to use them is a medical one to make with your GP or pharmacist.

First, an important boundary

Fat Reduction Bristol is a non-surgical body-contouring clinic. We do not supply, prescribe or recommend weight-loss injections — that sits firmly with medical prescribers. What we can do is explain how this whole category works so you understand the science before speaking to a healthcare professional. Later on we will touch on how medical weight loss differs from body contouring, because the two are often confused.

What is GLP-1?

GLP-1 stands for glucagon-like peptide-1. It is an incretin hormone — a natural chemical messenger — produced in the L-cells of your small intestine whenever you eat. Its job is to help coordinate your body’s response to a meal: nudging insulin release, calming blood sugar and signalling fullness.

There is a catch, though. Natural GLP-1 is fragile. It has a half-life of just one to two minutes before an enzyme called DPP-4 breaks it down. In other words, your own GLP-1 fires briefly and vanishes almost immediately.

This is the clever bit behind the medicines. GLP-1 receptor agonists — the technical name for the injections — are synthetic molecules engineered to mimic that hormone while resisting rapid breakdown. Instead of lasting a couple of minutes, modern versions are designed to keep working across a full week from a single dose. The medicine is essentially a longer-lasting copy of a signal your body already uses.

The injections do not add a foreign chemical that overrides your biology. They amplify and prolong a natural fullness hormone you produce every time you eat — which is why the effect feels less like fighting your appetite and more like your appetite quietly settling down.

The four ways GLP-1 medicines work

The appeal of GLP-1 medicines comes from the fact that they act on several systems at once, rather than through a single trick. There are four core mechanisms.

1. Turning down appetite in the brain

GLP-1 receptors sit on neurons in the hypothalamus, the brain region that governs hunger and satiety. When the medicine activates them, appetite falls, cravings for high-calorie foods ease, and fullness arrives earlier in a meal. The medicines also stimulate GLP-1 receptors on the vagus nerve, reinforcing “I’m full” messages travelling from the gut up to the brain. People often describe smaller portions feeling satisfying and a noticeable drop in constant food thoughts.

2. Slowing the stomach

GLP-1 activation slows gastric emptying — the rate at which food leaves the stomach for the small intestine. Food staying put for longer sustains that full feeling after eating and blunts the blood-sugar spike that normally follows a meal. This delayed emptying is one of the main practical reasons people simply eat less. Worth noting: with long-acting medicines this particular effect can fade somewhat over time, a phenomenon called tachyphylaxis.

3. Releasing insulin only when it is needed

The medicines prompt the pancreas to release insulin — but only when blood glucose is elevated. This glucose-dependent switch is important: insulin release tapers off once blood sugar is normal, which dramatically lowers the risk of hypoglycaemia (a dangerous blood-sugar crash) compared with older diabetes drugs. It is also why the class can be used safely in people without diabetes.

4. Suppressing glucagon

Finally, GLP-1 activation dials down glucagon, a hormone that tells the liver to dump glucose into the bloodstream. Suppressing it helps keep fasting blood-sugar levels lower and prevents unwanted glucose rises. Together with the insulin effect, this is what makes GLP-1 medicines so useful in type 2 diabetes as well as weight management.

Beyond these four, GLP-1 medicines have been linked to a range of additional metabolic effects — a modest lift in energy expenditure, increased fat breakdown, improved cholesterol and triglyceride profiles, reduced liver fat, and cardioprotective benefits that appear partly independent of the weight loss itself.

Why they outperform willpower

Here is the part that reframes the whole conversation. Traditional dieting runs into a biological wall: as you lose weight, your body defends its old set point by ramping up hunger hormones, so appetite surges and most people regain the weight. It is not a failure of discipline — it is physiology pushing back.

GLP-1 medicines work by recalibrating those hunger set points, softening the compensatory appetite rebound that normally sabotages diet-and-exercise attempts. That is why clinical trials report average weight loss in the region of 15 to 22 percent with GLP-1 medicines, against the 3 to 5 percent typical of behavioural changes alone.

The same mechanism explains their biggest limitation. Because the effect depends on the ongoing signal, weight tends to return quickly once the medication stops and the natural appetite rebound switches back on. This is a well-recognised pattern, and we explore it in depth in our guide to what happens when you stop weight-loss injections.

Not all GLP-1 injections are the same

“GLP-1 injection” is an umbrella term, and the medicines within it differ. Three active ingredients dominate the UK conversation, all prescription-only:

The most significant recent development is the arrival of a second hormone in the mix. Alongside GLP-1, there is another incretin called GIP (glucose-dependent insulinotropic polypeptide). Tirzepatide — the ingredient in Mounjaro — is the first medicine to activate both the GIP and GLP-1 receptors at once. GIP further enhances insulin release and acts directly on fat tissue, and it appears to work synergistically with GLP-1 to produce greater weight loss than either receptor could achieve alone. This dual action is why tirzepatide tends to outperform single-target medicines in head-to-head studies.

If you want the detail on the individual medicines, we have dedicated explainers on Mounjaro (tirzepatide) and Wegovy (semaglutide).

Why these are prescription-only medicines

It is worth being clear about why GLP-1 injections are not sold like a supplement. They are prescription-only medicines because they are powerful, they have real side effects, and they need to be matched to the right person, dosed carefully and monitored over time. In the UK it is against the law to advertise prescription medicines to the public, and any responsible provider will insist on a proper clinical assessment.

The scale of demand makes this caution all the more important. NHS spending on Mounjaro alone reached £574 million in 2025–26 — the highest ever annual spend on a single drug in NHS England’s history — yet only around 1 percent of those clinically eligible can currently access it through the NHS, which is why the private market has grown so rapidly. High demand and easy online availability are exactly the conditions in which people are tempted to skip proper medical oversight. Please don’t. If you are curious whether these medicines are right for you, that is a conversation for your GP or a registered pharmacist who can review your health history.

Medical weight loss versus body contouring

One common source of confusion is worth clearing up. GLP-1 injections drive overall weight loss — they shrink fat across the whole body by changing how much you eat and how your metabolism behaves. What they do not do is target a specific area or sculpt a contour. They also cannot address the loose skin or facial volume loss that can follow rapid, large-scale weight loss.

Non-surgical body contouring is a different tool for a different job. Treatments such as fat freezing and EMSculpt are designed to refine stubborn, localised pockets of fat — or build muscle tone — once your weight is already stable. They are not weight-loss treatments and are no substitute for medical care where that is needed. Many people think of the two as sitting at different stages of a journey: medical weight loss to reduce overall body fat, and body contouring later to fine-tune the areas that remain.

The bottom line

GLP-1 weight-loss injections are not magic and they are not a gimmick. They are a genuine medical advance that works by amplifying a natural gut hormone to curb appetite, steady blood sugar and recalibrate the biological signals that usually make weight loss so hard to sustain. They are also serious, prescription-only medicines with meaningful limitations — including the tendency for weight to return once they are stopped.

If medical weight loss is what you are weighing up, the right next step is a proper conversation with your GP or pharmacist, who can assess your suitability safely. And if, further down the line, your focus shifts to refining specific stubborn areas once your weight is stable, the team at Fat Reduction Bristol is here to talk you honestly through your non-surgical body-contouring options — and to tell you plainly if the timing isn’t right yet. Book a consultation whenever you would like a clear, no-pressure assessment.